 Call Kai
Call Kai Learn
Learn Practice Test
Practice Test Spaced Repetition
Spaced Repetition Match
Match1/28
Looks like no tags are added yet.
| Name | Mastery | Learn | Test | Matching | Spaced | 
|---|
No study sessions yet.
Gene Therapy
The introduction, removal or change in genetic material in the cells of a patient to treat an inherited or developed disease.
Gene Addiction
involves inserting a new copy of a gene into the target cells to produce more of a protein.
Gene Correction
can be achieved by modifying part of a gene using recently-developed gene editing technology (e.g. CRISPR/cas9, TALEN or ZFN) to remove repeated or faulty elements of a gene, or to replace a damaged or dysfunctional region of DNA.
Goal of Gene Correction
Produce a protein that functions in a normal manner instead of in a way that contributes to disease.
Gene Sliencing
Inactivating or “knocking out” a mutated gene.
Reprogramming
Involves adding one or more genes to cells of a specific type to change the characteristics of those cells.
Cell elimination
Used to destroy malignant (cancerous) tumor cells, but can also be used to target overgrowth of benign (non-cancerous) tumor cells.
Somatic Cell
targets only the genes in a patient’s body cell, so only the individual who receives the therapy is affected
Germ Line
targets the genes in a patient’s egg or sperm, so changes can be passed on to offspring & not in development
Transgene
It is an experimentally constructed piece of DNA that has integrated into the genome of a recipient organism.
Cell Therapy
The transfer of cells into a patient with the goal of improving a disease
CAR-T cell therapy
Example of Cell Therapy
CAR-T cell therapy
A patient’s T cells, which are a kind of immune cell, are changed in a lab by using a vector to add a gene that changes cells in a way that enables them to recognize and attack cancer cells.
Embryonic stem cells (ESCs)
These are pluripotent stem cells (can give rise to all the types of cell) derived from embryos.
Induced pluripotent stem cells (iPSCs)
A differentiated adult (somatic) cell, such as skin cell is \ reprogrammed to return to a pluripotent state.
Nuclear transfer embryonic stem cells (ntESCs)
These pluripotent cells are produced by transferring the nucleus from an adult cell obtained from the patient to an oocyte (egg cell) obtained from a donor.
Hematopoietic stem cells (HSCs)
are multipotent blood stem cells that give rise to all types of blood cells.
Immune cell therapy
The cells can be removed from the body, isolated from a mixed cell population, modified & then expanded before return to the body.
Mesenchymal, Neural, Epithelial
Other stem cell sources
Stem Cells
Basic cells that have the capacity to create more stem cells & to differentiate into different cell types
Adult stem cells
These stem cells are found in small numbers in most adult tissues, such as bone marrow or fat. Compared with embryonic stem cells, adult stem cells have a more limited ability to give rise to various cells of the body.
Embryonic stem cells
These stem cells come from embryos that are 3 to 5 days old. At this stage, an embryo is called a blastocyst and has about 150 cells.
pluripotent stem cells
they can divide into more stem cells or can become any type of cell in the body. This allows embryonic stem cells to be used to regenerate or repair diseased tissue and organs.
Induced pluripotent cells
are regular skin, fat, liver, nerve, or other cells that scientists have modified to behave like embryonic stem cells
Totipotent
These stem cells can differentiate into all possible cell types. The first few cells that appear as the zygote starts to divide.
Pluripotent
These cells can turn into almost any cell. Cells from the early embryo are pluripotent.
Multipotent
These cells can be differentiate into a closely related family of cells. Adult hematopoietic stem cells, for example, can become red & white blood cells or platelets.
Dolly the sheep
the poster child of modern biotechnology. It was the first mammal to have been successfully cloned from an adult cell.
Administrative Order No. 2013-0012
prohibits and restricts the creation, importation, promotion, marketing and use of stem cell therapies from embryonic, aborted fetal, and genetically altered, animal and plant stem cells.